Depression Management Skills: Putting Them
Into Practice

Introduction

John Williams, MD, Associate Professor of Medicine and Psychiatry, Duke University School of Medicine has been a leader in developing and validating clinical tools for the diagnosis and assessment of treatment of depression. Dr Williams reviews practical depression management approaches for the primary care physician and supplements these with videos of physician/patient encounters.

Intended Audience

This continuing medical education program is intended for primary care physicians and other healthcare professionals who manage patients with depressive disorders.

Educational Objectives

After completing this activity, participants should be better able to do the following:

• Practice scoring and interpreting the PHQ-9
• Demonstrate approach to incorporating PHQ-9 into practice
• Apply a structured approach to suicide evaluation
• Describe the common co-morbid psychiatric illnesses and screening approaches for bipolar disorder, alcohol abuse, post-traumatic stress disorder, and generalized anxiety disorder.
• Consider issues of patient preference for different forms of therapy (eg major forms of psychotherapy, combined antidepressant/psychotherapy, or antidepressants only) and medication adherence.

Information on CME credit

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Medical Association designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Instructions for CME credit

This online enduring material is presented as an audio webcast with attendant slide presentation. To receive credit, please listen to and view all of the presentations of this CME activity and evaluate the content presented. Complete both the pre- and post-test and activity evaluation.

The estimated time to complete this activity, including pre-test, review of the materials, and self-assessment and evaluation is 1.0 hour.

Principal Faculty

Wayne Katon, MD, Planning Committee Chair, Content Reviewer
Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Health Services and Psychiatric Epidemiology
University of Washington School of Medicine
Seattle, WA

Michael S. Klinkman, MD, Planning Committee, Content Reviewer
Associate Professor, Department of Medicine
Associate Professor, Department of Psychiatry
Department of Family Medicine
Director, Primary Care Programs
University of Michigan Depression Center
Ann Arbor, MI

Kurt Kroenke, MD, Planning Committee, Content Reviewer
Professor of Medicine
Indiana University School of Medicine
Research Scientist, Regenstrief Institute, Inc.
Indianapolis, IN

Jeffrey Susman, MD, Author/Presenter
Professor and Chair
Department of Family Medicine
University of Cincinnati College of Medicine
Cincinnati, OH

John Williams, MD, Planning Committee, Author/Presenter
Associate Professor of Medicine and Psychiatry
General Medicine
Duke University School of Medicine
Durham, NC

R. Mark Evans, PhD, Planning Committee, Content Reviewer
Director, Healthcare Education Products and Standards
American Medical Association
Chicago, IL

Kristi Eidsvoog, PhD, Planning Committee, Content Reviewer
Content Manager
MedEd Architects, LLC
Chicago, IL

Patti Fitzgerald
Manager, Product Development, Healthcare Education Products and Standards
American Medical Association
Chicago, IL

Faculty

Disclosure Policy

In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commercial Support, the AMA requires that all faculty and planning committee members disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being presented. We therefore obtain a completed disclosure and attestation form to inform the participant of any pertinent relationships disclosed, provided here.

These materials have been peer-reviewed by the members of the CME Advisory Board and the AMA Editorial Board to ensure the continued scientific accuracy and medical relevance of information presented and its independence from commercial bias. The AMA has control over all final content.

Dr. Katon: Advisory Board, Lilly, Wyeth; Speakers Bureau, Pfizer, Forest, GlaxoSmithKline

Dr. Klinkman: Advisory Board, Wyeth; Research Grant, Lilly; Independent Contractor, GE/Healthology

Dr. Kroenke: Research Grant, Lilly, Pfizer, Wyeth; Consultant, Lilly, Pfizer, Wyeth

Dr. Susman: Advisory Board, Pfizer, Forest, Wyeth; Consultant, Pfizer, Forest, Wyeth; Speaker's Bureau, Pfizer, Forest , Wyeth

Dr. Williams: Nothing relevant to disclose

Dr. Evans: Nothing relevant to disclose

Dr. Eidsvoog: Nothing relevant to disclose

Ms. Fitzgerald: Nothing relevant to disclose

Acknowledgement of Support

This CME publication was supported through an independent education grant from Eli Lilly & Company and produced in accordance with the AMA Standards for Industry-Supported Multimedia Continuing Medical Education and Other Communications.

Term of approval

Original Release Date- June 2008

Date of the Most Recent Release- July 2009

Expiration Date- December 2010